Cannara Biotech Balance Sheet Health
Financial Health criteria checks 1/6
Cannara Biotech has a total shareholder equity of CA$79.3M and total debt of CA$48.7M, which brings its debt-to-equity ratio to 61.4%. Its total assets and total liabilities are CA$145.8M and CA$66.5M respectively. Cannara Biotech's EBIT is CA$11.4M making its interest coverage ratio 2.4. It has cash and short-term investments of CA$3.1M.
Key information
61.4%
Debt to equity ratio
CA$48.68m
Debt
Interest coverage ratio | 2.4x |
Cash | CA$3.13m |
Equity | CA$79.34m |
Total liabilities | CA$66.48m |
Total assets | CA$145.82m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LOVF.F's short term assets (CA$58.2M) do not cover its short term liabilities (CA$60.1M).
Long Term Liabilities: LOVF.F's short term assets (CA$58.2M) exceed its long term liabilities (CA$6.4M).
Debt to Equity History and Analysis
Debt Level: LOVF.F's net debt to equity ratio (57.4%) is considered high.
Reducing Debt: LOVF.F's debt to equity ratio has increased from 38.9% to 61.4% over the past 5 years.
Debt Coverage: LOVF.F's debt is not well covered by operating cash flow (16.6%).
Interest Coverage: LOVF.F's interest payments on its debt are not well covered by EBIT (2.4x coverage).